Loading…

CLINICAL OUTCOMES AND MOLECULAR CHARACTERIZATION FROM a PHASE II STUDY OF COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2017-06, Vol.35 (S2), p.68-69
Main Authors:	Lenz, G., Hawkes, E., Verhoef, G., Haioun, C., Lim, S., Heo, D., Ardeshna, K., Chong, G., Christensen, J.H., Shi, V., Lippert, S., Hiemeyer, F., Piraino, P., Beckmann, G., Peña, C., Buvaylo, V., Childs, B.H., Gorbatchevsky, I., Salles, G.
Format:	Article
Language:	English
Subjects:	B-cell lymphoma Lymphocytes B Lymphoma Patients
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!